References
- Aggarwal R, Naik S. 2009. Epidemiology of hepatitis E: current status. J. Gastroenterol. Hepatol. 24: 1484-1493. https://doi.org/10.1111/j.1440-1746.2009.05933.x
- Arankalle VA, Chobe LP, Chadha MS. 2006. Type-IV Indian swine HEV infects rhesus monkeys. J. Viral Hepat. 13: 742-745. https://doi.org/10.1111/j.1365-2893.2006.00759.x
- Teshale EH, Hu DJ, Holmberg SD. 2010. The two faces of hepatitis E virus. Clin. Infect. Dis. 51: 328-334. https://doi.org/10.1086/653943
- Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. 1992. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull. World Health Organ. 70: 597-604.
- Ricci A, Allende A, Bolton D, Chemaly M, Davies R, Escamez PSF, et al. 2017. Public health risks associated with hepatitis E virus (HEV) as a food-borne pathogen. EFSA J. 15.
- Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, et al. 2007. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J. Gastroenterol. Hepatol. 22: 676-682. https://doi.org/10.1111/j.1440-1746.2007.04913.x
- Navaneethan U, Al Mohajer M, Shata MT. 2008. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 28: 1190-1199. https://doi.org/10.1111/j.1478-3231.2008.01840.x
- Pavio N, Meng XJ, Doceul V. 2015. Zoonotic origin of hepatitis E. Curr. Opin. Virol. 10: 34-41. https://doi.org/10.1016/j.coviro.2014.12.006
- Meng XJ. 2010. Hepatitis E virus: animal reservoirs and zoonotic risk. Vet. Microbiol. 140: 256-265. https://doi.org/10.1016/j.vetmic.2009.03.017
- Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, et al. 1991. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185: 120-131. https://doi.org/10.1016/0042-6822(91)90760-9
- Koonin EV, Gorbalenya AE, Purdy MA, Rozanov MN, Reyes GR, Bradley DW. 1992. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc. Natl. Acad. Sci. USA 89: 8259-8263. https://doi.org/10.1073/pnas.89.17.8259
- Graff J, Torian U, Nguyen H, Emerson SU. 2006. A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus. J. Virol. 80: 5919-5926. https://doi.org/10.1128/JVI.00046-06
- Ropp SL, Tam AW, Beames B, Purdy M, Frey TK. 2000. Expression of the hepatitis E virus ORF1. Arch. Virol. 145: 1321-1337. https://doi.org/10.1007/s007050070093
- Sehgal D, Thomas S, Chakraborty M, Jameel S. 2006. Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein. Virol. J. 3: 38. https://doi.org/10.1186/1743-422X-3-38
- Suppiah S, Zhou Y, Frey TK. 2011. Lack of processing of the expressed ORF1 gene product of hepatitis E virus. Virol. J. 8: 245. https://doi.org/10.1186/1743-422X-8-245
- Graff J, Zhou YH, Torian U, Nguyen H, St Claire M, Yu C, et al. 2008. Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles. J. Virol. 82: 1185-1194. https://doi.org/10.1128/JVI.01219-07
- Shiota T, Li TC, Yoshizaki S, Kato T, Wakita T, Ishii K. 2013. The hepatitis E virus capsid C-terminal region is essential for the viral life cycle: implication for viral genome encapsidation and particle stabilization. J. Virol. 87: 6031-6036. https://doi.org/10.1128/JVI.00444-13
- Qi Y, Zhang F, Zhang L, Harrison TJ, Huang W, Zhao C, et al. 2015. Hepatitis E virus produced from cell culture has a lipid envelope. PLoS One 10: e0132503. https://doi.org/10.1371/journal.pone.0132503
- Yamada K, Takahashi M, Hoshino Y, Takahashi H, Ichiyama K, Nagashima S, et al. 2009. ORF3 protein of hepatitis E virus is essential for virion release from infected cells. J. Gen. Virol. 90: 1880-1891. https://doi.org/10.1099/vir.0.010561-0
- Nagashima S, Takahashi M, Jirintai, Tanaka T, Yamada K, Nishizawa T, et al. 2011. A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells. J. Gen. Virol. 92: 269-278. https://doi.org/10.1099/vir.0.025791-0
- Kenney SP, Pudupakam RS, Huang YW, Pierson FW, LeRoith T, Meng XJ. 2012. The PSAP motif within the ORF3 protein of an avian strain of the hepatitis E virus is not critical for viral infectivity in vivo but plays a role in virus release. J. Virol. 86: 5637-5646. https://doi.org/10.1128/JVI.06711-11
- Nair VP, Anang S, Subramani C, Madhvi A, Bakshi K, Srivastava A, et al. 2016. Endoplasmic reticulum stress induced synthesis of a novel viral factor mediates efficient replication of genotype-1 hepatitis E virus. PLoS Pathog. 12: e1005521. https://doi.org/10.1371/journal.ppat.1005521
- Theofilopoulos AN, Baccala R, Beutler B, Kono DH. 2005. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-336. https://doi.org/10.1146/annurev.immunol.23.021704.115843
- Xi Y, Day SL, Jackson RJ, Ranasinghe C. 2012. Role of novel type I interferon epsilon in viral infection and mucosal immunity. Mucosal. Immunol. 5: 610-622. https://doi.org/10.1038/mi.2012.35
- Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. 2015. Type I interferons in anticancer immunity. Nat. Rev. Immunol. 15: 405-414. https://doi.org/10.1038/nri3845
- Kang S, Myoung J. 2017. Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas. J. Microbiol. 55: 319-329. https://doi.org/10.1007/s12275-017-7075-2
- Yarilina A, Ivashkiv LB. 2010. Type I interferon: a new player in TNF signaling. Curr. Dir. Autoimmun. 11: 94-104.
- Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801. https://doi.org/10.1016/j.cell.2006.02.015
- Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826. https://doi.org/10.1038/nature06246
- Fujita T, Onoguchi K, Onomoto K, Hirai R, Yoneyama M. 2007. Triggering antiviral response by RIG-I-related RNA helicases. Biochimie 89: 754-760. https://doi.org/10.1016/j.biochi.2007.01.013
- Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6: 981-988. https://doi.org/10.1038/ni1243
- Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172. https://doi.org/10.1038/nature04193
- Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682. https://doi.org/10.1016/j.cell.2005.08.012
- Hardy MP, Mc GAF, O'Neill LA. 2004. Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene. Biochem. J. 380: 83-93. https://doi.org/10.1042/bj20040030
- Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, et al. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643. https://doi.org/10.1126/science.1087262
- Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, et al. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4: 491-496.
- Chau TL, Gioia R, Gatot JS, Patrascu F, Carpentier I, Chapelle JP, et al. 2008. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated? Trends Biochem. Sci. 33: 171-180. https://doi.org/10.1016/j.tibs.2008.01.002
- Hacker H, Karin M. 2006. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006: re13.
- Gatot JS, Gioia R, Chau TL, Patrascu F, Warnier M, Close P, et al. 2007. Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. J. Biol. Chem. 282: 31131-31146. https://doi.org/10.1074/jbc.M701690200
- Clement JF, Meloche S, Servant MJ. 2008. The IKK-related kinases: from innate immunity to oncogenesis. Cell Res. 18: 889-899. https://doi.org/10.1038/cr.2008.273
- Grandvaux N, Servant MJ, tenOever B, Sen GC, Balachandran S, Barber GN, et al. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76: 5532-5539. https://doi.org/10.1128/JVI.76.11.5532-5539.2002
- Honda K, Taniguchi T. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6: 644-658. https://doi.org/10.1038/nri1900
- Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, et al. 2015. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347: aaa2630. https://doi.org/10.1126/science.aaa2630
- Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, et al. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777. https://doi.org/10.1038/nature03464
- Hiscott J, Grandvaux N, Sharma S, Tenoever BR, Servant MJ, Lin R. 2003. Convergence of the NF-kappaB and interferon signaling pathways in the regulation of antiviral defense and apoptosis. Ann. NY Acad. Sci. 1010: 237-248. https://doi.org/10.1196/annals.1299.042
- Wang J, Basagoudanavar SH, Wang X, Hopewell E, Albrecht R, Garcia-Sastre A, et al. 2010. NF-kappa B RelA subunit is crucial for early IFN-beta expression and resistance to RNA virus replication. J. Immunol. 185: 1720-1729. https://doi.org/10.4049/jimmunol.1000114
- Song JW, Guan M, Zhao ZW, Zhang JJ. 2015. Type I interferons function as autocrine and paracrine factors to induce autotaxin in response to TLR activation. PLoS One 10.
- Hu J, Lou DH, Carow B, Winerdal ME, Rottenberg M, Wikstrom AC, et al. 2012. LPS Regulates SOCS2 transcription in a type I interferon dependent autocrine-paracrine loop. PLoS One 7.
- Draenert R, Frater J, Prado JG. 2012. Virus immune evasion: new mechanism and implications in disease outcome. Adv. Virol. 2012: 490549.
- Senba M, Mori N. 2012. Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection. Oncol. Rev. 6: e17. https://doi.org/10.4081/oncol.2012.e17
- Wi J, Jeong MS, Hong HJ. 2017. Construction and Characterization of an anti-hepatitis B virus preS1 humanized antibody that binds to the essential receptor binding site. J. Microbiol. Biotechnol. 27: 1336-1344. https://doi.org/10.4014/jmb.1703.03066
- Bode JG, Ludwig S, Ehrhardt C, Albrecht U, Erhardt A, Schaper F, et al. 2003. IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J. 17: 488-490. https://doi.org/10.1096/fj.02-0664fje
- Lin W, Kim SS, Yeung E, Kamegaya Y, Blackard JT, Kim KA, et al. 2006. Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J. Virol. 80: 9226-9235. https://doi.org/10.1128/JVI.00459-06
- Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285: 107-110. https://doi.org/10.1126/science.285.5424.107
- Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, et al. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 102: 2992-2997. https://doi.org/10.1073/pnas.0408824102
- Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. 2005. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. USA 102: 17717-17722. https://doi.org/10.1073/pnas.0508531102
- Kang SM, Won SJ, Lee GH, Lim YS, Hwang SB. 2010. Modulation of interferon signaling by hepatitis C virus non-structural 5A protein: implication of genotypic difference in interferon treatment. FEBS Lett. 584: 4069-4076. https://doi.org/10.1016/j.febslet.2010.08.032
- Lan KH, Lan KL, Lee WP, Sheu ML, Chen MY, Lee YL, et al. 2007. HCV NS5A inhibits interferon-alpha signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines. J. Hepatol. 46: 759-767.
- Kang S, Myoung J. 2017. Host innate immunity against hepatitis E virus and viral evasion mechanisms. J. Microbiol. Biotechnol. 27: 1727-1735. https://doi.org/10.4014/jmb.1708.08045
- Zhou X, Xu L, Wang W, Watashi K, Wang Y, Sprengers D, et al. 2016. Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection. J. Viral. Hepat. 23: 294-304. https://doi.org/10.1111/jvh.12491
- Krain LJ, Nelson KE, Labrique AB. 2014. Host immune status and response to hepatitis E virus infection. Clin. Microbiol. Rev. 27: 139-165. https://doi.org/10.1128/CMR.00062-13
- Nan Y, Yu Y, Ma Z, Khattar SK, Fredericksen B, Zhang YJ. 2014. Hepatitis E virus inhibits type I interferon induction by ORF1 products. J. Virol. 88: 11924-11932. https://doi.org/10.1128/JVI.01935-14
- Karpe YA, Lole KS. 2011. Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease. J. Gen. Virol. 92: 2088-2092. https://doi.org/10.1099/vir.0.033738-0
- Oshiumi H, Miyashita M, Matsumoto M, Seya T. 2013. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog. 9: e1003533. https://doi.org/10.1371/journal.ppat.1003533
- Hamid FB, Kim J, Shin CG. 2017. Characterization of prototype foamy virus infectivity in transportin 3 knockdown human 293t cell line. J. Microbiol. Biotechnol. 27: 380-387. https://doi.org/10.4014/jmb.1606.06011
- Myoung J, Ganem D. 2011. Infection of lymphoblastoid cell lines by Kaposi's sarcoma-associated herpesvirus: critical role of cell-associated virus. J. Virol. 85: 9767-9777. https://doi.org/10.1128/JVI.05136-11
- Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J. Virol. Methods. 174: 12-21. https://doi.org/10.1016/j.jviromet.2011.03.012
- Myoung J, Ganem D. 2011. Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells. Virology 413: 1-11. https://doi.org/10.1016/j.virol.2010.12.036
- Myoung J, Ganem D. 2011. Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells. J. Clin. Invest. 121: 1130-1140. https://doi.org/10.1172/JCI43755
- Johne R, Trojnar E, Filter M, Hofmann J. 2016. Thermal stability of hepatitis E virus as estimated by a cell culture method. Appl. Environ. Microbiol. 82: 4225-4231. https://doi.org/10.1128/AEM.00951-16
- Kang HS, Myoung J, So EY, Bahk YY, Kim BS. 2016. Transgenic expression of non-structural genes of Theiler's virus suppresses initial viral replication and pathogenesis of demyelination. J. Neuroinflammation 13: 133. https://doi.org/10.1186/s12974-016-0597-4
- Ha S, Choi IS, Choi C, Myoung J. 2016. Infection models of human norovirus: challenges and recent progress. Arch. Virol. 161: 779-788. https://doi.org/10.1007/s00705-016-2748-4
- Cho M, Myoung J. 2015. OX40 and 4-1BB downregulate Kaposi's sarcoma-associated herpesvirus replication in lymphatic endothelial cells, but 4-1BB and not OX40 inhibits viral replication in B-cells. J. Gen. Virol. 96: 3635-3645. https://doi.org/10.1099/jgv.0.000312
- Lee JM, Kim J, Ryu I, Woo HM, Lee TG, Jung W, et al. 2017. An aptamer-based electrochemical sensor that can distinguish influenza virus subtype H1 from H5. J. Microbiol. Biotechnol. 27: 2037-2043. https://doi.org/10.4014/jmb.1708.08015
- Lee JM, Cho JB, Ahn HC, Jung W, Jeong YJ. 2017. A novel chemical compound for inhibition of SARS coronavirus helicase. J. Microbiol. Biotechnol. 27: 2070-2073. https://doi.org/10.4014/jmb.1707.07073
- Choi S, Park H, Minelko M, Kim EK, Cho MR, Nam JH. 2017. Recombinant adeno-associated virus expressing truncated IK cytokine diminishes the symptoms of inflammatory arthritis. J. Microbiol. Biotechnol. 27: 1892-1895. https://doi.org/10.4014/jmb.1705.05018
- Yoo JE, Lee C, Park S, Ko G. 2017. Evaluation of various real-time reverse transcription quantitative PCR assays for norovirus detection. J. Microbiol. Biotechnol. 27: 816-824. https://doi.org/10.4014/jmb.1612.12026
- Shin JS, Ku KB, Jang Y, Yoon YS, Shin D, Kwon OS, et al. 2017. Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate. J. Microbiol. 55: 979-983. https://doi.org/10.1007/s12275-017-7371-x
- Jeong H, Seong BL. 2017. Exploiting virus-like particles as innovative vaccines against emerging viral infections. J. Microbiol. 55: 220-230. https://doi.org/10.1007/s12275-017-7058-3
- Kim JH, Lee CH, Lee SW. 2016. Hepatitis C virus infection stimulates transforming growth factor-beta1 expression through up-regulating miR-192. J. Microbiol. 54: 520-526. https://doi.org/10.1007/s12275-016-6240-3
- Elkholy YS, Hegab AS, Ismail DK, Hassan RM. 2016. Evaluation of a novel commercial quaternary ammonium compound for eradication of Mycobacteria, HCV and HBV in Egypt. J. Microbiol. 54: 39-43. https://doi.org/10.1007/s12275-016-5530-0
- Kim MJ, Lee SY, Kim HJ, Lee JS, Joo IS, Kwak HS, et al. 2016. Development of a one-step duplex RT-PCR method for the simultaneous detection of VP3/VP1 and VP1/P2B regions of the hepatitis A virus. J. Microbiol. Biotechnol. 26: 1398-1403. https://doi.org/10.4014/jmb.1604.04047
- Ahn HS, Han SH, Kim YH, Park BJ, Kim DH, Lee JB, et al. 2017. Adverse fetal outcomes in pregnant rabbits experimentally infected with rabbit hepatitis E virus. Virology 512: 187-193. https://doi.org/10.1016/j.virol.2017.09.020
- Lee M, Seo DJ, Seo J, Oh H, Jeon SB, Ha SD, et al. 2015. Detection of viable murine norovirus using the plaque assay and propidium-monoazide-combined real-time reverse transcription-polymerase chain reaction. J. Virol. Methods 221: 57-61. https://doi.org/10.1016/j.jviromet.2015.04.018
- Gillen J, Li W, Liang Q, Avey D, Wu J, Wu F, et al. 2015. A survey of the interactome of Kaposi's sarcoma-associated herpesvirus ORF45 revealed its binding to viral ORF33 and cellular USP7, resulting in stabilization of ORF33 that is required for production of progeny viruses. J. Virol. 89: 4918-4931. https://doi.org/10.1128/JVI.02925-14
- Fu B, Kuang E, Li W, Avey D, Li X, Turpin Z, et al. 2015. Activation of p90 ribosomal S6 kinases by ORF45 of Kaposi's sarcoma-associated herpesvirus is critical for optimal production of infectious viruses. J. Virol. 89: 195-207. https://doi.org/10.1128/JVI.01937-14
- Lim S, Cha S, Jang JH, Yang D, Choe J, Seo T. 2016. Alterations in acetylation of histone H4 lysine 8 and trimethylation of lysine 20 associated with lytic gene promoters during Kaposi's sarcoma-associated herpesvirus reactivation. J. Microbiol. Biotechnol.
- Schemmerer M, Apelt S, Trojnar E, Ulrich RG, Wenzel JJ, Johne R. 2016. Enhanced replication of hepatitis E virus strain 47832c in an A549-derived subclonal cell line. Viruses 8.
- Devhare PB, Chatterjee SN, Arankalle VA, Lole KS. 2013. Analysis of antiviral response in human epithelial cells infected with hepatitis E virus. PLoS One 8: e63793. https://doi.org/10.1371/journal.pone.0063793
- Malmgaard L. 2004. Induction and regulation of IFNs during viral infections. J. Interferon. Cytokine Res. 24: 439-454. https://doi.org/10.1089/1079990041689665
- Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, et al. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82: 335-345. https://doi.org/10.1128/JVI.01080-07
- Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820. https://doi.org/10.1016/j.cell.2010.01.022
Cited by
- The Amino-Terminal Region of Hepatitis E Virus ORF1 Containing a Methyltransferase (Met) and a Papain-Like Cysteine Protease (PCP) Domain Counteracts Type I Interferon Response vol.10, pp.12, 2018, https://doi.org/10.3390/v10120726
- Cell culture systems for the study of hepatitis E virus vol.163, pp.None, 2018, https://doi.org/10.1016/j.antiviral.2019.01.007
- Immunocontraceptive Effects in Male Rats Vaccinated with Gonadotropin-Releasing Hormone-I and -II Protein Complex vol.29, pp.4, 2019, https://doi.org/10.4014/jmb.1901.01067
- Zika Virus Proteins NS2A and NS4A Are Major Antagonists that Reduce IFN-β Promoter Activity Induced by the MDA5/RIG-I Signaling Pathway vol.29, pp.10, 2019, https://doi.org/10.4014/jmb.1909.09017
- Chikungunya Virus-Encoded nsP2, E2 and E1 Strongly Antagonize the Interferon-β Signaling Pathway vol.29, pp.11, 2018, https://doi.org/10.4014/jmb.1910.10014
- Methyltransferase of a cell culture-adapted hepatitis E inhibits the MDA5 receptor signaling pathway vol.57, pp.12, 2019, https://doi.org/10.1007/s12275-019-9478-8
- Identification of Hepatitis E Virus in Bovine and Porcine Raw Livers vol.29, pp.12, 2019, https://doi.org/10.4014/jmb.1910.10059
- Middle East Respiratory Syndrome Coronavirus-Encoded ORF8b Inhibits RIG-I-Like Receptors by a Differential Mechanism vol.29, pp.12, 2018, https://doi.org/10.4014/jmb.1911.11024
- Chikungunya Virus nsP2 Impairs MDA5/RIG-I-Mediated Induction of NF-κB Promoter Activation: A Potential Target for Virus-Specific Therapeutics vol.30, pp.12, 2020, https://doi.org/10.4014/jmb.2012.12005
- Interplay between Hepatitis E Virus and Host Cell Pattern Recognition Receptors vol.22, pp.17, 2018, https://doi.org/10.3390/ijms22179259
- Hepatitis E virus‐encoded microRNA promotes viral replication by inhibiting type I interferon vol.36, pp.1, 2022, https://doi.org/10.1096/fj.202101042r